We found that METTL14 (adjusted p-value = 9.10e-08), WTAP (adjusted p-value = 2.86e-07), KIAA1429 (adjusted p-value = 2.33e-06), RBM15 (adjusted p-value = 1.52e-03), ZC3H13 (adjusted p-value = 5.56e-12), YTHDC1 (adjusted p-value = 1.68e-03), YTHDF1 (adjusted p-value = 4.72e-27), YTHDF2 (adjusted p-value = 4.72e-02), HNRNPC (adjusted p-value = 1.60e-24), and FTO (adjusted p-value = 2.62e-33) were significantly abnormally expressed in breast cancer compared to normal tissues (Figure 1B). This evidence concerns the gene FTO and breast cancer.